Hjem
Nils Erik Gilhuss bilde

Nils Erik Gilhus

Professor, Professor
  • E-postNils.Gilhus@uib.no
  • Telefon+47 55 97 50 74+47 55 97 50 44
  • Besøksadresse
    Gamle Hovedbygg, Haukeland Universitetssjukehus
    5021 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • 2010. Traumatic spinal cord injury and concomitant brain injury: a cohort study. Acta Neurologica Scandinavica. 51-57.
  • 2010. Publishing affects funding in neurology. European Journal of Neurology. 147-151.
  • 2010. Neurofilament ELISA validation. JIM - Journal of Immunological Methods. 23-31.
  • 2010. Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. European Journal of Neurology. 1445-1450.
  • 2010. Mortality after traumatic spinal cord injury: 50 years of follow-up. Journal of Neurology, Neurosurgery and Psychiatry. 368-373.
  • 2010. Maternal epilepsy and adverse pregnancy outcomes. Expert Review of Obstetrics & Gynecology. 347-355.
  • 2010. MRI of the transverse and alar ligaments in rheumatoid arthritis: feasibility and relations to atlantoaxial subluxation and disease activity. Neuroradiology. 215-223.
  • 2010. Guidelines for treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology. 893-902.
  • 2010. Extrathymic malignancies in thymoma patients with and without myasthenia gravis. Journal of the Neurological Sciences. 66-69.
  • 2010. Delivery outcome of women with epilepsy:a population-based cohort study. BJOG: an International Journal of Obstetrics and Gynaecology. 1537-1543.
  • 2010. Cost of disorders of the brain in Norway. Acta Neurologica Scandinavica. 1-5.
  • 2010. Clinical aspects of myasthenia explained. Autoimmunity. 344-352.
  • 2010. Are MRI high-signal changes of alar and transverse ligaments in acute whiplash injury related to outcome? BMC Musculoskeletal Disorders.
  • 2010. Anti-heat shock protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barre syndrome. Journal of Neuroimmunology. 180-183.
  • 2010. A 50-year follow-up of the incidence of traumatic spinal cord injuries in Western Norway. Spinal Cord. 313-318.
  • 2009. Seropositive myasthenia gravis: a nationwide epidemiologic study. Neurology. 150-151.
  • 2009. Pregnancy, delivery, and outcome for the child in maternal epilepsy. Epilepsia. 2130-2139.
  • 2009. Norwegian neurology: present status and future trends. Acta Neurologica Scandinavica. 5-7.
  • 2009. Myasthenia gravis in the elderly. Aging Health. 561-568.
  • 2009. MRI of the alar and transverse ligaments in whiplash-associated disorders (WAD) grades 1–2: high-signal changes by age, gender, event and time since trauma. Neuroradiology. 227-235.
  • 2009. Interleukin-10 promoter polymorphisms in myasthenia gravis. Journal of Neuroimmunology. 63-66.
  • 2009. Diagnostic coding accuracy for traumatic spinal cord injuries. Spinal Cord. 367-371.
  • 2009. Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG: an International Journal of Obstetrics and Gynaecology. 1736-1742.
  • 2009. Characteristics of generalised epileptiform activity. Clinical Neurophysiology. 3-10.
  • 2009. Autoimmune myasthenia gravis. Expert Review of Neurotherapeutics. 351-358.
  • 2008. Titin and ryanodine receptor antibodies and neurmuscular involvement in myasthenia gravis. Future Neurology. 87-92.
  • 2008. Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis. Journal of Neuroimmunology. 96-99.
  • 2008. Report of the Task Force on pre-graduate education in Europe of the education committee of the European Federation of Neurological Societies Composition of the task force of the education committee on pre-graduate education. European Journal of Neurology. e103-e109.
  • 2008. Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. Journal of Neurology. 623-627.
  • 2008. Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis. Journal of Neuroimmunology. 28-32.
  • 2008. Norsk nevrologi markerer seg internasjonalt. Axonet. 18.
  • 2008. Myasthenia gravis sera have no effect on cardiomyocytes in vitro. Journal of Neuroimmunology. 74-79.
  • 2008. Myasthenia Gravis and the Heart. Advances in Clinical Neuroscience & Rehabilitation. 9-10.
  • 2008. Left ventricular long-axis function in myasthenia gravis. Journal of Neurology. 1777-1784.
  • 2008. A retrospective view on research in neuroscience in Norway. Acta Neurologica Scandinavica. 3-5.
  • 2007. Pregnancy, delivery and perinatal outcome in female survivors of polio. Journal of the Neurological Sciences. 27-32.
  • 2007. Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. European Journal of Neurology. 60-65.
  • 2007. Polygenic disease associations in thymomatous myasthenia gravis. Archives of Neurology. 1729-1733.
  • 2007. Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features. European Journal of Neurology. 617-620.
  • 2007. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. European Journal of Neurology. 38-43.
  • 2007. Is smoking an extra hazard in pregnant MS women? Findings from a population-based registry in Norway. European Journal of Neurology. 1113-1117.
  • 2007. Focal epileptiform activity described by a large computerised EEG database. Clinical Neurophysiology. 1369-1376.
  • 2006. Titin and ryanodine receptor antibodies in myasthenia gravis. Acta Neurologica Scandinavica. 19-23.
  • 2006. Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. Acta Neurologica Scandinavica. 51-54.
  • 2006. Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. Acta Neurologica Scandinavica. 51-54.
  • 2006. Morphological effects of myasthenia gravis patient sera on human muscle cells. Muscle and Nerve. 93-103.
  • 2006. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. European Journal of Neurology. 913-922.
  • 2006. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology. 691-699.
  • 2006. EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. European Journal of Neurology. 795-801.
  • 2006. Does myasthenia gravis provide protection against cancer? Acta Neurologica Scandinavica. 33-36.
  • 2006. Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001. Journal of Neurology, Neurosurgery and Psychiatry. 203-207.
  • 2006. Bergen International symposium in neuroimmunology 2006. Introduction. Acta Neurologica Scandinavica, Supplementum. v-vi.
  • 2006. Artrogryposis multiplex congenita - a rare fetal condition caused by maternal myasthenia gravis. Acta Neurologica Scandinavica. 26-27.
  • 2005. The role of complement in myasthenia gravis; serological evidence of complement consumption in vivo. Journal of Neuroimmunology. 191-194.
  • 2005. Seronegative myasthenia gravis; disease severity and prognosis. European Journal of Neurology. 413-418.
  • 2005. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology. 1961-1963.
  • 2005. Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease. Neurology. 459-462.
  • 2005. Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease. Neurology. 459-462.
  • 2005. Fordypningsstillinger er en forskningsressurs. Tidsskrift for Den norske legeforening. 2224-2225.
  • 2005. Fordypningsstillinger er en forskningsressurs. Tidsskrift for Den norske legeforening. 2224-2225.
  • 2004. Asymptomatic myasthenia gravis influences pregnancy and birth. European Journal of Neurology. 559-562.
  • 2003. Thymectomy in non-thymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies. European Neurology. 210-217.
  • 2003. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis. Annals of the New York Academy of Sciences. 481-490.
  • 2003. Three forms of immune myasthenia. Annals of the New York Academy of Sciences. 453-456.
  • 2003. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. Muscle &Nerve. 81-89.
  • 2003. Research and specialty associations of the Medical Society. Tidsskrift for Den norske legeforening. 1370-1371.
  • 2003. Post polio syndrome and total health status in a prospective health study. European Journal of Neurology. 407-413.
  • 2003. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies. Annals of the New York Academy of Sciences. 350-353.
  • 2003. Om helsetjenesten. Fordypningsstillinger for å fremme medisinsk forskning. Tidsskrift for Den norske legeforening. 3415-3416.
  • 2003. Myesthenia gravis: Consequenses for pregnancy, delivery, and the newborn. Neurology. 1362-1366.
  • 2003. Myasthenia gravis. Consequences for pregnancy, delivery, and the newborn. Neurology. 1362-1366.
  • 2003. Myasthenia gravis in individuals over forty. Annals of the New York Academy of Sciences. 424-431.
  • 2003. MRI of the tectorial and posterior atlanto-occipital membranes in the late stage of whiplash injury. Neuroradiology. 585-591.
  • 2003. MR analysis of the transverse ligament in the late stage of whiplash injury. Acta Radiologica. 637-644.
  • 2003. Long term outcome after poliomyelitis in different health and social conditions. Journal of Epidemiology and Community Health. 368-372.
  • 2003. Arvelige muskelsykdommer. Tidsskrift for Den norske legeforening. 2588-2592.
  • 2002. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with co-stimulatory molecules. Journal of Neuroimmunology. 82-89.
  • 2002. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. European Journal of Neurology. 55-61.
  • 2002. The recognition, diagnosis and management of cerebral vasculitis: a European survey. European Journal of Neurology. 343-347.
  • 2002. Open Facilities for Training in European Neurology (OFTEN): a European Board of Neurology initiative. European Journal of Neurology. 349-352.
  • 2002. Nevrololgiforskning i Norge. Axonet. 4-5.
  • 2002. MRI assessment of the alar ligaments in the late stage of whiplash injury - a study of structural abnormlities and observer agreement. Neuroradiology. 617-624.
  • 2002. Klasehodepine ("cluster Headache"). GlaxoSmithKline.
  • 2002. Forskning og forbindelser. Tidsskrift for Den norske legeforening. 1235.
  • 2002. Former poliomyelitis as a health and socioeconomic factor. A paired sibling study. Journal of Neurology. 404-409.
  • 2002. Education, occupation, and perception of health amongst previous polio patients compared to their siblings. European Journal of Neurology. 233-241.
  • 2001. Why research courses for medical students? Tidsskrift for Den norske legeforening. 1846-1847.
  • 2001. Task force on minimum standards for health care of people with multiple sclerosis. European Journal of Neurology. 215-220.
  • 2001. Polio survivors - well educated and hard working. Journal of Neurology. 500-505.
  • 2001. Neurology training abroad; OFTEN - a new european programme. Federation of Neurological Societies EFNS Newsletter. 2.
  • 2001. MRI assessment of normal ligamentous structures in the craniovertebral junction. Neuroradiology. 1089-1097.
  • 2001. MRI assessment of normal ligamentous structures in the craniovertebral junction. Neuroradiology. 1089-97.
  • 2001. Autoimmunity against the ryanodine receptor in myasthenia gravis. Acta Physiologica Scandinavica. 379-384.
  • 2000. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Archives of Neurology. 1596-1600.
  • 2000. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Archives of Neurology. 1596-1600.
  • 2000. Pasienter med clusterhodepine ved en nevrologisk avdeling. Tidsskrift for Den norske legeforening. 3510-3512.
  • 2000. Pasienter med clusterhodepine ved en nevrologisk avdeling. Tidsskrift for Den norske legeforening. 3510-3512.
  • 2000. Muscle autoantibodies in subgroups of myasthenia gravis patients. Journal of Neurology. 369-375.
  • 2000. Muscle autoantibodies in subgroups of myasthenia gravis patients. Journal of Neurology. 369-375.
  • 2000. European minimum standards for multiple sclerosis. WFNR update. 2-6.
  • 2000. EFNS Task Force Report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres. European Journal of Neurology. 625-628.
  • 2000. Controversies in diagnosis and treatment. Proct 5th EFNS Congress, Copenhagen. 1-9.
  • 2000. Controversies in diagnosis and treatment. Proct 5th EFNS Congress, Copenhagen. 1-9.
  • 2000. Complement activation by titin and ryanoidine receptor autoantibodies in myasthenia gravis. Journal of Neuroimmunology. 169-176.
  • 2000. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. Journal of Neuroimmunology. 169-176.
  • 2000. Autoantibodies in Thymoma-Associated Myasthenia Gravis With Myositis or Neuromyotonia. Archives of Neurology. 527-531.
  • 1998. Titin transcripts in thymoma. Annals of the New York Academy of Sciences. 422-426.
  • 1998. The histomorphology of the thymus in late onset, non-thymoma myasthenia gravis. European Journal of Neurology. 401-405.
  • 1998. Sårbutulisme ved heroinmisbruk. Tidsskrift for Den norske legeforening. 4363-4365.
  • 1998. Sårbotulisme ved heroinmisbruk. Tidsskrift for Den norske legeforening. 4357-4359.
  • 1998. Striational autoantibodies in myasthenia gravis patients recognizw I-band titin epitopes. Journal of Neuroimmunology. 98-108.
  • 1998. Polio; en akutt og epidemisk infeksjonssykdom. Polio. 6-11.
  • 1998. Nevrodagene 1990-97 - bred faglig mønstring for norske nevrologer. Tidsskrift for Den norske legeforening. 2953-2956.
  • 1998. Myasthenia gravis-associated ryanodine receptor antibodies inhibit binding of ryanodine to sarcoplasmic reticulum. Annals of the New York Academy of Sciences. 530-533.
  • 1998. Myasthenia gravis sera containing anti-ryanodine receptor antibodies inhibit binding of (3H-) ryanodine to sarcoplasmic reticulum. Muscle and Nerve. 329-335.
  • 1998. Muscle striation antibodies in myasthenia gravis; diagnostic and functional significance. Annals of the New York Academy of Sciences. 505-515.
  • 1998. FcgRIIA and RIIIB polymorphisms in myasthenia gravis. Journal of Neuroimmunology. 173-176.
  • 1998. Cell-mediated immune response against titin in myasthenia gravis; evidence for the involvment of Th1 and Th2 cells. Scandinavian Journal of Immunology. 76-82.
  • 1997. Trends in neurological rehabilitation: More resources required in Norway. WFNR update. 4-5.
  • 1997. Titin transcript in thymomas. Journal of Autoimmunity. 551-557.
  • 1997. Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of titin. European Journal of Neurology. 131-137.
  • 1997. Standards in neurological rehabilitation; an EFNS Report. European Journal of Neurology. 325-331.
  • 1997. Postpoliosyndromet; en reell komplikasjon. Tidsskrift for Den norske legeforening. 510-513.
  • 1997. Poliomyelitis: long-time consequences for social life. Acta Neurologica Scandinavica. 353-358.
  • 1997. Nevrologers arbeidsoppgave er høyspesialisert legearbeid. Axonet. 4-5.
  • 1997. Nevrologer;en etterspurt ressurs. Axonet. 3-4.
  • 1997. Neurology in Norway. [abstract]. World Neurology. 5.
  • 1997. Neurology in Norway. World Neurology. S. 5.
  • 1997. Diagnostikk av thymom og thymusatrofi hos pasienter med myasthenia gravis. Tidsskrift for Den norske legeforening. 4212-4214.
  • 1997. Diagnostikk av thymom og thumusatrofi hos pasienter med myasthenia gravis. Tidsskrift for Den norske legeforening. 4212-4214.
  • 1997. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. Autoimmunity. 111-116.
  • 1997. Arbeidsoppgaver for nevrologer - og for Norsk Neurologisk Forening. Axonet. 3-5.
  • 1996. Neurologi - kan rekrutteringen dekke behovet? Tidsskrift for Den norske legeforening. 3354-3358.
  • 1993. Titin antibodies in myasthenia gravis; identification of a major immunogenic region of titin. Neurology. 1581-1585.
  • 1993. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma. Journal of Autoimmunity. 507-515.
  • 1992. Non-receptor muscle antibodies in myasthenia gravis are of IgGi and IgG4 subclasses. Autoimmunity. 271-276.
  • 1992. Myasthenia gravis with thymoma is not associated with an increased incidence of non-muscle autoimmune disorders. Autoimmunity. 159-162.
  • 1992. Myasthenia gravis muscle antibodies examined by ELISA: IgG and IgM antibodies characterize different patient subgroups. Acta Neurologica Scandinavica. 233-238.
  • 1991. Myasthenia Gravis with Thymoma is not Associated with an Increased incidence of Non-muscle Autoimmune Disorders. Autoimmunity. 159-162.
  • 1991. Cerebral luftemboli etter perkutan lungepunksjon. Tidsskrift for Den norske legeforening. 3173-3175.
Vitenskapelig foredrag
  • 2013. Doesmother’s epilepsy or its treatment affect the brain of the child?
  • 2013. Anxiety and depression before and after delivery in pregnant women with epilepsy - A prospective, population based study.
  • 2002. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with co-stimulatory molecules.
  • 2002. Deliveries among women affected by myasthenia gravis in Norway 1967-1998.
  • 2001. Thymectomy and muscle autoantibodies in myasthenia gravis.
  • 2001. Long-time consequences of poliomylitis in Norway and Estonia.
  • 2001. Influence of previous polio on socioeconomic factors and general health evaluated by matched pair analysis.
  • 2001. Behandling av myasthenia gravis; kontrollerte undersøkelser og klinisk erfaring.
  • 2001. Autoimmunity against the ryanodine receptor in myasthenia gravis.
  • 2001. Autoimmunity against the ryanodine receptor in myasthenia gravis.
  • 1998. Thymus dysfunction and thymectomy in myasthenia gravis.
Vitenskapelig antologi/Konferanseserie
  • 2015. Novel Challenges in Myasthenia Gravis. Nova Science Publishers, Inc..
  • 2015. Handbook of Neurological Therapy. Oxford University Press.
  • 2012. European Handbook of Neurological Management, Volume 2. Wiley-Blackwell.
  • 2011. Screening for tumours in paraneoplastic syndromes. Wiley-Blackwell.
  • 2011. Intravenous immunoglobulin in the treatment of neurological diseases. Wiley-Blackwell.
  • 2011. European Handbook of Neurological Management. Volume 2. Wiley-Blackwell.
  • 2011. European Handbook of Neurological Management. Wiley-Blackwell.
  • 2006. European Handbook of Neurological Management. Blackwell Publishing.
Sammendrag/abstract
  • 2011. Revised EFNS guidelines for diagnosis and management of post-polio syndrome. Journal of Rehabilitation Medicine. 12.
  • 2011. PSYCHIATRIC DISEASE AND SOCIAL CHARACTERISTICS IN WOMEN WITH EPILEPSY. THE MoBa DATABASE. European Journal of Neurology. 182-182.
  • 2010. Traumatic spinal cord injury and concomitant brain injury: a 50-year cohort study. European Journal of Neurology. 66-66.
  • 2010. Myasthenia gravis (MG) in the elderly and MG with anti-ryanodine receptor (RyR) antibodies. European Journal of Neurology. 628-628.
  • 2009. Poliomyelitis: beyond the year 2000. Journal of the Neurological Sciences. S6-S6.
  • 2009. Myasthenia gravis requiring drug treatment in a national population cohort. European Journal of Neurology. S207.
  • 2009. Interleukin-10 promoter polymorphisms in myasthenia gravis. European Journal of Neurology. 49-49.
  • 2009. Health and development in children born to mothers with epilepsy. European Journal of Neurology. 46-46.
  • 2009. Geographical distribution of the Norwegian seropositive myasthenia gravis population. European Journal of Neurology. 221-221.
  • 2008. The risk of extrathymic malignancies in thymoma patients with and without myasthenia gravis. European Journal of Neurology. 150-150.
  • 2008. Scientific activity within the European federation of neurological societies by Norwegian and British neurologists. Journal of Neurology, Neurosurgery and Psychiatry. 346-346.
  • 2008. Respiratory and cardiovascular dysfunctions are the main causes of death after traumatic spinal cord injury. European Journal of Neurology. 18-18.
  • 2008. Cytotoxic effects of myasthenia gravis sera on cardiomyocytes in vitro. Journal of Neuroimmunology. 154-155.
  • 2008. Acetylcholine receptor antibodies in Norwegian myasthenia gravis patients. European Journal of Neurology. 154-154.
  • 2007. Smoking habits in pregnant MS women. European Journal of Neurology. 278-278.
  • 2007. Pregnancy, delivery and outcome for the child in maternal epilepsy. European Journal of Neurology. 27-28.
  • 2007. Perinatal factors and later development of multiple sclerosis. Multiple Sclerosis. S91-S92.
  • 2007. Focal epileptiform activity described by a large computerised EEG database. European Journal of Neurology. 224-224.
  • 2006. Pregnancy, delivery and birth outcome in mothers prior to debut of multiple sclerosis. European Journal of Neurology. 28-29.
  • 2006. Pregnancy, birth and perinatal outcome in women with former polio - Health aspects of polio sequel in fertile age. European Journal of Neurology. 30-30.
  • 2006. Myasthenia gravis in pregnancy - Identifying risk factors, optimizing care. European Journal of Neurology. 24-24.
  • 2006. Does myasthenia gravis provide protection against cancer? European Journal of Neurology. 24-24.
Vitenskapelig oversiktsartikkel/review
  • 2019. Myasthenia gravis - optimal treatment in severe disease. 81-85.
  • 2019. Myasthenia gravis. 1-19.
  • 2018. Developing treatment guidelines for myasthenia gravis. 95-101.
  • 2017. Pathophysiology and immunological profile of myasthenia gravis and its subgroups. 9-13.
  • 2016. Myasthenia gravis - Autoantibody characteristics and their implications for therapy. 259-268.
  • 2016. Myasthenia gravis. 2570-2581.
  • 2016. International consensus guidance for management of myasthenia gravis: Executive summary. 419-425.
  • 2015. Myasthenia gravis: Subgroup classification and therapeutic strategies. 1023-1036.
  • 2015. Myasthenia gravis and risks for comorbidity. 17-23.
  • 2015. Epilepsy and recommendations for breastfeeding. 57-65.
  • 2015. Depression and anxiety during pregnancy and the postpartum period in women with epilepsy: A review of frequency, risks and recommendations for treatment. 39-45.
  • 2015. Complicating autoimmune diseases in myasthenia gravis: A review. 362-368.
  • 2012. Traumatic spinal cord injuries - incidence, mechanisms and course. 831-837.
  • 2012. Serum levels of matrix metalloproteinases: Implications in clinical neurology. 121-128.
  • 2012. Pregnancy complications in patients with epilepsy. 78-83.
  • 2012. Myasthenia and the neuromuscular junction. 523-529.
  • 2012. Advances in the treatment of myasthenia gravis. 701-708.
  • 2011. Treatment for postpolio syndrome. 92 sider.
  • 2011. Heat-Shock Proteins in Clinical Neurology. 65-69.

Se fullstendig oversikt over publikasjoner i CRIStin.